Dr. Luca Cindolo

Born on 27 January 1973 in Potenza. In 1991 he obtained the classical high school diploma. He graduated in July 1997 with an experimental thesis "Galectins expression in human bladder carcinoma" with a score of 110/110 cum laude. He obtained specialization in Urology in October 2002 on "Molecular cancerogenesis of the urothelium: the role of HOX genes" with vote 70/70. In 2018 he completed a PhD program in Translational Medicine with a thesis on "Use of Abiraterone Acetate in real life". After specialization he worked at the National Cancer Institute of Naples as a scholarship and then at the “G. Rummo" of Benevento from 2005 to 2008 as Urologist. He moved to the Urology Unit of the ASL Abruzzo2 at the "S. Pio da Pietrelcina" Hospital in Vasto until 2018. From 2014 to 2018 he held the role of head of the Simple Operative Unit of Urological Robotics at the "SS Annunziata" of Chieti. Since the end of 2018 he has held the role of Referent for Urology of Villa Stuart in Rome. Since 2020, with other partners, he has founded the European Urological Center CURE and is its advisor for scientific activity and development manager of the Central SOUTH Italy area. He is the author of more than 240 articles of international relevance (published in PUBMED). In his career he has participated in more than 170 national and international congresses; as a speaker you have taken part in at least 90 scientific meetings on the most diverse topics in urology.